Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pirfenidone”

126 trials

Showing 20 of 126 results

Testing effectiveness (Phase 2)Study completedNCT00076102
What this trial is testing

Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas

Who this might be right for
Neurofibromatosis 1Neurofibroma, Plexiform
National Cancer Institute (NCI) 36
Early research (Phase 1)UnknownNCT04126538
What this trial is testing

Pirfenidone Capsule in Patients With Chronic Kidney Disease G2 and G3a Study on Safety and Pharmacokinetics

Who this might be right for
Renal Insufficiency
Beijing Continent Pharmaceutical Co, Ltd. 24
Early research (Phase 1)Not Yet RecruitingNCT07229716
What this trial is testing

Study on the Drug Interactions of HRS-9813, Pirfenidone and Nintedanib in Healthy Subjects

Who this might be right for
Pulmonary Fibrosis
Guangdong Hengrui Pharmaceutical Co., Ltd 20
Not applicableStudy completedNCT00020631
What this trial is testing

Pirfenidone in Treating Patients With Fibrosis Caused by Radiation Therapy for Cancer

Who this might be right for
Radiation Fibrosis
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Study completedNCT00662038
What this trial is testing

Open-Label Study of the Long Term Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Genentech, Inc. 1,058
Testing effectiveness (Phase 2)Study completedNCT02136992
What this trial is testing

Clinical Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Shanghai Pulmonary Hospital, Shanghai, China 160
Post-approval studies (Phase 4)UnknownNCT05505409
What this trial is testing

Efficacy and Safety of Pirfenidone in CTD-ILD

Who this might be right for
PirfenidoneConnective Tissue DiseasesInterstitial Lung Disease
Qilu Hospital of Shandong University 120
Large-scale testing (Phase 3)UnknownNCT02496182
What this trial is testing

Pirfenidone in the Chronic Hypersensitivity Pneumonitis Treatment

Who this might be right for
Alveolitis Extrinsic AllergicPulmonary Fibrosis
Grupo Medifarma, S. A. de C. V. 60
Large-scale testing (Phase 3)Looking for participantsNCT05288179
What this trial is testing

Efficacy and Safety of Pirfenidone Capsules in the Treatment of Pneumoconiosis

Who this might be right for
Pneumoconiosis
Beijing Continent Pharmaceutical Co, Ltd. 272
Not applicableNot Yet RecruitingNCT07404423
What this trial is testing

OPEN-IPF: Observational Prediction modEl for cliNical Outcomes in Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
University of Modena and Reggio Emilia 1,000
Large-scale testing (Phase 3)UnknownNCT03857854
What this trial is testing

Efficacy and Safety of Pirfenidone in Patient With Dermatomyositis Interstitial Lung Disease (Dm-ILD)

Who this might be right for
Dermatomyositis Interstitial Lung Disease (Dm-ILD)
Beijing Continent Pharmaceutical Co, Ltd. 152
Testing effectiveness (Phase 2)Study completedNCT00080223
What this trial is testing

Safety Study of Oral Pirfenidone in Patients With Pulmonary Fibrosis/Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary FibrosisPulmonary Fibrosis
Genentech, Inc. 83
Testing effectiveness (Phase 2)UnknownNCT01504334
What this trial is testing

Safety and Efficacy Study of Pirfenidone to Treat Idiopathic Pulmonary Fibrosis(IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Beijing Kawin Technology Share-Holding Co., Ltd. 80
Early research (Phase 1)Study completedNCT03315741
What this trial is testing

The Safety and Tolerability of Pirfenidone for BOS After HCT

Who this might be right for
Bronchiolitis ObliteransGraft Vs Host Disease
Stanford University 30
Post-approval studies (Phase 4)Study completedNCT02606877
What this trial is testing

Compare the Amount of Nintedanib and Pirfenidone in the Blood When Nintedanib and Pirfenidone Are Given Separately or in Combination

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 37
Not applicableStudy completedNCT03958071
What this trial is testing

A Study Based on Medical Records That Looks at the Characteristics of Idiopathic Pulmonary Fibrosis Patients Grouped by the Type of Medication They Are Taking

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 13,264
Not applicableStudy completedNCT05826821
What this trial is testing

Biomarkers in HF: Circulating Biomarkers of Fibrosis and Cardiovascular Disease

Who this might be right for
Heart Failure With Preserved Ejection Fraction
Manchester University NHS Foundation Trust 107
Early research (Phase 1)Study completedNCT03981094
What this trial is testing

The Pharmacokinetic Interaction Between Pirfenidone and BMS-986278 in Healthy Participants

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
Bristol-Myers Squibb 22
Large-scale testing (Phase 3)Not Yet RecruitingNCT07082842
What this trial is testing

Confirmatory Clinical Study of HEC585 Tablets in Patients With IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
Sunshine Lake Pharma Co., Ltd. 472
Early research (Phase 1)Study completedNCT07456800
What this trial is testing

PK of Deupirfenidone Versus Pirfenidone in Older Healthy Subjects

Who this might be right for
Pharmacokinetic Analysis
PureTech 116
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation